| Health / Medical Topics |
Figitumumab
A human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab selectively binds to IGF1R, preventing insulin-like growth factor type 1 (IGF1) from binding to the receptor and subsequent receptor autophosphorylation. Inhibition of IGF1R autophosphorylation may result in a reduction in receptor expression on tumor cells that express IGF1R, a reduction in the anti-apoptotic effect of IGF, and inhibition of tumor growth. IGF1R is a receptor tyrosine kinase expressed on most tumor cells and is involved in mitogenesis, angiogenesis, and tumor cell survival. (NCI Thesaurus)
YOU MAY ALSO LIKE
A group of changes that occur in the body to help a person fight or take flight in stressful or dangerous…
Human FIGF wild-type allele is located in the vicinity of Xp22.31 and is approximately 39 kb in length. This allele, which encodes…
This gene plays a role in angiogenesis, lymphangiogenesis, and endothelial cell growth.
A characteristic of a medicinal product, specifying that its most predominant agreeable savor detected by the unified sensation of taste and olfactory…
A natural number greater than fifty-eight and less than sixty and the quantity that it denotes.
A natural number greater than forty-nine and less than fifty-one and the quantity that it denotes.
